The MCL31 Dermablate Erbium:YAG laser ablates the skin with a degree of precision that can be measured in microns and can be carried out as a fully ablative or fractional process. This allows a safely and gently remove of wide variety of lesions from the skin at epidermis and dermis level and an effective ablative skin resurfacing. Its reliability and effectiveness have been proven worldwide.
The wavelength of 2,940 nm of the Erbium laser matches the maximum peak of water absorption (water is the main component of the skin). The energy is therefore entirely used for the rapid vaporization of the water in the tissue, which leads to the almost instant ablation of tissue. Due to its characteristics, the MCL31 Dermablate has a significantly shorter healing time compared to a CO2 laser (time for re-epithelialization, erythema, edema). On the other hand, the CO2 laser results in better hemostasis thanks to coagulation.
Thanks to the greatly limited thermal effects of the Erbium laser, the procedure is less painful than with CO2 lasers. Patients do not require any anesthesia in the treatment of small lesions. Side effects and risks are greatly reduced with this laser. The safety of this treatment makes the Erbium laser the superior choice for delicate areas such as the periorbital region or even the neck, chest and hands.